Publications by authors named "Barbara Simi"

Claim this Profile
C
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Nanjoo Suh, Bandaru S Reddy, Andrew DeCastro, Shiby Paul, Hong Jin Lee, Barbara Simi

Cancer Prev Res (Phila)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.
Shiby Paul, Andrew J DeCastro, Hong Jin Lee, Amanda K Smolarek, Jae Young So, Barbara Simi

Carcinogenesis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats.
Yingying Liu, Jihyeung Ju, Hang Xiao, Barbara Simi, Xingpei Hao

Nutr Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats.
Hang Xiao, Xingpei Hao, Barbara Simi, Jihyeung Ju, Heyuan Jiang

Carcinogenesis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.
Nanjoo Suh, Shiby Paul, Xingpei Hao, Barbara Simi, Hang Xiao

Clin Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Chinthalapally V Rao, Bandaru S Reddy, Vernon E Steele, C-X Wang, Xiaoping Liu, Barbara Simi

Mol Cancer Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Bandaru S Reddy, Jagan M Patlolla, Barbara Simi, S H Wang, Chinthalapally V Rao

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
Malisetty V Swamy, Indranie Cooma, Jagan M R Patlolla, Barbara Simi, Bandaru S Reddy

Mol Cancer Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
Bhagavathi A Narayanan, Narayanan K Narayanan, Barbara Simi, Bandaru S Reddy

Cancer Res· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Chinthalapally V Rao, Cooma Indranie, Barbara Simi, Pamela T Manning, Jane R Connor

Cancer Res· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis